In conclusion, this study reveals that the natural product derivative ACT001 exhibits potential cytotoxicity against SCLC cells and regulates tumor glycolysis and anti‐tumor immunity by targeting PGK1. This evidence concerns the gene PGK1 and small cell lung carcinoma.